PMDA drug package insert
イフェクサーSRカプセル37.5mg
PMDA Prescription drug · ヴィアトリス製薬合同会社 · package insert Mar 23, 2026
Key facts
| Brand names | イフェクサーSRカプセル37.5mg, イフェクサーSRカプセル75mg |
|---|---|
| Nonproprietary names | ベンラファキシン塩酸塩 |
| Companies | 製造販売元／ヴィアトリス製薬合同会社 |
| Product type | Prescription drug |
| Therapeutic category | セロトニン・ノルアドレナリン再取り込み阻害剤 |
| Therapeutic category codes | 871179 |
| YJ codes | 1179055N1021, 1179055N2028 |
| Approval numbers | 22700AMX01007, 22700AMX01008 |
| Package insert edition | 第8版 |
| Package insert date | Mar 23, 2026 |
| PMDA document key | 671450_1179055N1021_3 |
| PMDA company code | 671450 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: